We are Sorry, This Page doesn't Exist

AstraZeneca on Wednesday beat analysts' estimates for first-quarter profit and reiterated its outlook for 2020, as demand for the company's newer medicines remained steady......»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

The FTSE 100-listed drug maker reported that core operating profit slid 29% to $1.55 billion......»»

Yum Brands shares fell after its quarterly same-store sales and profit missed analyst expectations Thursday, as stiff competition took a bite out of sales at its Pizza Hut chain in the United States. Fred Katayama reports.....»»

Yum Brands Inc shares fell 4.7% after it reported quarterly same-store sales and profit that missed analyst expectations on Thursday, as stiff competition took a bite out of sales at its Pizza Hut chain in the United States......»»

Yum Brands Inc reported quarterly same-store sales and profit that missed market expectations on Thursday, as sales at its Pizza Hut chain in the United States were hurt by stiff competition......»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 30) 0 read more.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Sc.....»»

Roche Holding AG said Thursday that sales and profit increased in 2019, and it guided for further growth in the year ahead despite biosimilar competition......»»

A group of Blue Cross Blue Shield insurers is investing $55 million in a new venture with a non-profit generic drug manufacturer to try to offer cheaper prices on pharmacy drugs to their members, the companies said on Thursday......»»

Manufacturer AbbVie raised the drug’s cost by more than 7 percent at the start of 2020......»»

Manufacturer AbbVie raised the drug’s cost by more than 7 percent at the start of 2020......»»

Manufacturer AbbVie raised the drug’s cost by more than 7 percent at the start of 2020......»»

Seven pharma companies face generic competition for medications that generated high U.S. sales in 2018Related Stocks: RHHBY, GILD, PFE, AMGN, GSK, INDV,.....»»

Generic drugmaker Mylan NV beat Wall Street estimates for third-quarter profit on Tuesday, benefiting from drug launches such as Wixela and Fulphila, sending its shares up 2% before the opening bell......»»

Mylan NV reported a 7.4% rise in third-quarter profit on Tuesday, as the generic drugmaker benefited from new product launches......»»

The consumer-electronics maker said it expects intense price competition from its rivals to be a drag, as the shopping season for some of its flagship products approaches......»»

Shares of Amgen Inc. rose less than 1% in the extended session Tuesday after the pharma company beat third-quarter adjusted profit and revenue expectations even as its sales fell due to more competition. Amgen said it earned $1.97 billion, or .....»»

Amgen Inc on Tuesday said competition for older off-patent drugs sent third-quarter revenue down 3%, but share repurchases and biosimilar sales helped it achieve higher-than-expected profit, and the company raised its full-year outlook......»»

Beyond Meat Inc reported its first ever net profit and raised its full-year sales forecast, but shares tumbled 6.5% in extended trading as the vegan burger maker said it would need to offer more store discounts or promotions as competition heats up......»»